S-268019

N/A

Report date: 2024/08/27 11:12:58

Base Information

Drug NameS-268019

Drug Alias NameCOVGOZES-268019

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Biological material > Viral vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)

Approved Indications in ChinaN/A

Original Approved Country/TerritoryJapan

Original Approved Date2024/06/24

Country/TerritoryVietnamJapan

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesShionogi & Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShionogi & Co Ltd

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A